Glencore plc
Glencore plc (GLNCY) Financial Performance & Income Statement Overview
Analyze Glencore plc (GLNCY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Glencore plc (GLNCY) Income Statement & Financial Overview
View the income breakdown for Glencore plc GLNCY across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $113.85B | $117.09B | $108.96B | $107.38B |
| Cost of Revenue | $110.27B | $114.39B | $102.71B | $102.11B |
| Gross Profit | $3.59B | $2.70B | $6.25B | $5.27B |
| Gross Profit Ratio | $0.03 | $0.02 | $0.06 | $0.05 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.20B | $1.009B | $1.09B | $1.05B |
| Operating Expenses | $1.20B | $1.009B | $1.09B | $1.05B |
| Total Costs & Expenses | $111.47B | $115.40B | $103.80B | $103.16B |
| Interest Income | $0.00 | $0.00 | $289.65M | $321.00M |
| Interest Expense | $0.00 | $0.00 | $1.20B | $1.03B |
| Depreciation & Amortization | $3.84B | $2.68B | $3.72B | $2.83B |
| EBITDA | $5.47B | $4.38B | $3.75B | $9.08B |
| EBITDA Ratio | $0.05 | $0.04 | $0.08 | $0.07 |
| Operating Income | $2.39B | $1.69B | $5.16B | $4.22B |
| Operating Income Ratio | $0.02 | $0.01 | $0.05 | $0.04 |
| Other Income/Expenses (Net) | -$3.01B | -$2.06B | -$6.31B | $1.78B |
| Income Before Tax | -$628.00M | -$370.00M | -$1.15B | $5.24B |
| Income Before Tax Ratio | -$0.006 | -$0.003 | -$0.01 | $0.05 |
| Income Tax Expense | $1.16B | $532.00M | $468.96M | $1.73B |
| Net Income | -$1.40B | -$233.00M | -$283.74M | $4.57B |
| Net Income Ratio | -$0.01 | -$0.002 | -$0.003 | $0.04 |
| EPS | -$0.12 | -$0.02 | -$0.05 | $0.73 |
| Diluted EPS | -$0.12 | -$0.02 | -$0.05 | $0.72 |
| Weighted Avg Shares Outstanding | $12.15B | $11.65B | $6.09B | $6.28B |
| Weighted Avg Shares Outstanding (Diluted) | $12.39B | $12.15B | $6.09B | $6.31B |
Over the past four quarters, Glencore plc demonstrated steady revenue growth, increasing from $107.38B in Q2 2023 to $113.85B in Q4 2024. Operating income reached $2.39B in Q4 2024, maintaining a consistent 2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $5.47B, reflecting operational efficiency. Net income dropped to -$1.40B, with EPS at -$0.12. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan